Prospective Multi-Center Evaluation of the Duration of Therapy for Thrombosis in Children

Trial Profile

Prospective Multi-Center Evaluation of the Duration of Therapy for Thrombosis in Children

Recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Mar 2017

At a glance

  • Drugs Dalteparin sodium (Primary) ; Enoxaparin sodium; Heparin; Warfarin
  • Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms Kids-DOTT
  • Most Recent Events

    • 21 Mar 2017 Planned End Date changed from 1 Dec 2020 to 30 Jun 2022.
    • 21 Mar 2017 Planned primary completion date changed from 1 Dec 2019 to 30 Jun 2021.
    • 30 Jan 2013 Planned number of patients changed from 1250 to 750 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top